Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 trial evaluating whether adding olanzapine to standard antiemetic therapy improves prevention of chemotherapy-induced nausea and vom…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability update of SNS-314 in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study by MedImmune evaluating safety and antitumor activity in adults with advanced solid tumors, including advanced recurrent ovari…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001) [Phase 1]
Phase 1 dose-escalation trial of dalotuzumab (MK-0646) in advanced solid tumors and multiple myeloma completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
The trial evaluating Retacrit (epoetin zeta), a biosimilar, for chemotherapy-induced symptomatic anemia in hematology and oncology has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer [Phase 1]
Phase 1 dose-escalation study of TAK-117 (MLN1117) in subjects with advanced metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients [NA]
A completed clinical trial tested two intensities of an intervention aimed at improving resilience and reducing supportive care needs in adu…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors [Phase 1]
Phase 1 trial of HuMax-IL8 for patients with advanced malignant solid tumors has completed, providing early safety and tolerability data.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies [Phase 1]
Phase 1 study assessing pharmacokinetic interactions between capecitabine and BMS-247550 in patients with advanced malignancies; the update …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Administration of BIIB028 to Subjects With Solid Tumors [Phase 1]
This entry reports the completion of a Phase 1 trial of BIIB028 in adults with advanced solid tumors, summarizing safety, tolerability, and …
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Study of KRN951 in Patients With Solid Tumors [Phase 1]
A Phase 1 study of the investigational agent KRN951 in patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety [Phase 1]
This Phase 1 study evaluated the effect of a single dose of NKTR-102 (etirinotecan pegol) on QTc interval and assessed pharmacokinetics and …
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies [Phase 1]
This entry reports completion of a Phase 1 study evaluating safety, tolerability, pharmacokinetics and activity of Oraxol in adults with adv…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors [Phase 1]
Phase 1 clinical trial update for MSC2156119J (c-Met inhibitor) in Japanese subjects with solid tumors; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of GDC-0917 in patients with refractory solid tumors or lymphoma has completed. The study assessed safety, tolerability, and p…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluating GDC-0980 in patients with refractory solid tumors or Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable [Phase 1]
Phase 1 study of GDC-0941 (pictilisib) in patients with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma; the trial has c…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors. [Phase 1]
Phase 1 study evaluating multiple ascending doses of the investigational cancer agent R4733 in patients with advanced solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating GDC-0980 administered once weekly in patients with refractory solid tumors or Non-Hodgkin's lymphoma has…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating AMG 479 in combination with biologics or chemotherapy for subjects with advanced solid tumors; the trial status is …
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment [Phase 1]
This Phase 1 trial evaluated the pharmacokinetics and safety of carfilzomib in patients with advanced solid tumors or hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours [Phase 1]
Phase I dose-escalation study of AZD8835 to assess safety and pharmacokinetics in patients with advanced solid tumors, including breast canc…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors [Phase 1]
A Phase 1 study of DKN-01 in multiple myeloma or advanced solid tumors has completed enrollment with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors [Phase 1]
A Phase I ascending multiple-dose study of BMS-986115 in subjects with advanced solid tumors was terminated.